Walgreens Boots Alliance (WBA) Cut to Sell at BidaskClub

BidaskClub downgraded shares of Walgreens Boots Alliance (NASDAQ:WBA) from a hold rating to a sell rating in a research note released on Tuesday morning.

A number of other equities analysts also recently commented on WBA. Zacks Investment Research raised shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $85.00 price objective for the company in a report on Sunday, January 21st. Needham & Company LLC reaffirmed a buy rating and issued a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday, January 10th. ValuEngine raised shares of Walgreens Boots Alliance from a hold rating to a buy rating in a report on Thursday, January 4th. Robert W. Baird reaffirmed a buy rating and issued a $82.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, January 4th. Finally, Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the stock a buy rating in a report on Wednesday, January 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of Buy and a consensus price target of $83.20.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ:WBA opened at $63.82 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45. The firm has a market capitalization of $63,575.68, a P/E ratio of 12.51, a P/E/G ratio of 1.04 and a beta of 1.16. Walgreens Boots Alliance has a 12-month low of $61.74 and a 12-month high of $87.79.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. The business had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The business’s revenue was up 12.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.36 earnings per share. equities research analysts predict that Walgreens Boots Alliance will post 5.95 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.51%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 31.37%.

In other news, insider Stefano Pessina purchased 98,858 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 15th. The stock was bought at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 14.80% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. raised its stake in shares of Walgreens Boots Alliance by 17.2% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 116,893 shares of the pharmacy operator’s stock valued at $8,489,000 after purchasing an additional 17,145 shares in the last quarter. Xact Kapitalforvaltning AB raised its stake in shares of Walgreens Boots Alliance by 5.9% during the fourth quarter. Xact Kapitalforvaltning AB now owns 177,533 shares of the pharmacy operator’s stock valued at $12,892,000 after purchasing an additional 9,960 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its stake in shares of Walgreens Boots Alliance by 63.3% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 740,953 shares of the pharmacy operator’s stock valued at $53,808,000 after purchasing an additional 287,243 shares in the last quarter. Sawtooth Solutions LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $376,000. Finally, We Are One Seven LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $869,000. 60.90% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance (WBA) Cut to Sell at BidaskClub” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/14/walgreens-boots-alliance-wba-cut-to-sell-at-bidaskclub.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply